Expansions and renovations to existing biological facilities – and construction of new facilities – provide a unique opportunity to rethink basic design strategies and use new technologies to build a better facility that will reduce costs and improve compliance. This webinar will discuss how process and regulations are changing the modern biotechnology facility and process design paradigm.
There are multiple variables that must be considered in the layout of a biopharmaceutical facility, and many of these variables are interdependent. The adoption of modern process systems and techniques are allowing for a shift in the balance of those variables to enable smaller and more flexible facilities. This will include the elimination of many of the utility areas, allow for rapid product/process change over, greater product integrity, and increased compliance. This webinar will explore modern facility design options and configurations, and the realities of building a facility around the today’s process technology.
Join us for this 90-minute, live, online seminar, where you will learn:
This course will be of benefit to anyone involved in the production, engineering, or quality operations of biotech facility or a team member assigned to a new biotech project. Additionally, those for communicating internally with engineering or operations personnel responsible for new production will find this course extremely beneficial.
Herman Bozenhardt has 40 years of experience in pharmaceutical, biotechnology, and medical device manufacturing, engineering, and compliance. He is a recognized expert in the area of aseptic filling facilities and systems and has extensive experience in the manufacture of therapeutic biologicals and vaccines. His current consulting work focuses on the areas of biotech technology transfer, biological manufacturing, and automation/computer systems. He has a B.S. in chemical engineering and an M.S. in system engineering, both from the Polytechnic Institute of Brooklyn.
Erich Bozenhardt is the Process Manager for IPS-Integrated Project Services’ process group in Raleigh, NC. He has 11 years of experience in the biotechnology and aseptic processing business and has led several biological manufacturing projects, including cell therapies, mammalian cell culture, and novel delivery systems. He has a B.S. in chemical engineering and an MBA, both from the University of Delaware.